Nadia Howlader

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States
    Nadia Howlader
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland Department of Epidemiology and Biostatistics, The George Washington University Milken Institute School of Public Health, Washington, D C
    Cancer Epidemiol Biomarkers Prev 25:1289-96. 2016
  2. pmc US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status
    Nadia Howlader
    Affiliations of authors Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda MD NH, SFA, LAGR, KAC Department of Epidemiology, University of Washington, Seattle, WA CIL Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA CIL Louisiana Tumor Registry and Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA VWC Cancer Prevention Institute of California, Fremont, CA CAC National Cancer Institute Contractor, RiesSearch, LLC, Rockville MD LAGR
    J Natl Cancer Inst 106:. 2014
  3. pmc Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends
    Nadia Howlader
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland Department of Epidemiology and Biostatistics, The George Washington University Milken Institute School of Public Health, Washington DC
    Cancer Epidemiol Biomarkers Prev 25:174-9. 2016
  4. pmc Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death
    Nadia Howlader
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD NH, AM Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT SW, LMS
    J Natl Cancer Inst Monogr 2014:255-64. 2014
  5. pmc The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries
    Nadia Howlader
    Cancer Statistic Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd Suite 504, Bethesda, MD 20892 8315, USA
    J Natl Cancer Inst 101:533-6. 2009
  6. pmc Improved estimates of cancer-specific survival rates from population-based data
    Nadia Howlader
    Data Analysis and Interpretation Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd, Ste 504, Bethesda, MD 20892 8315, USA
    J Natl Cancer Inst 102:1584-98. 2010
  7. ncbi request reprint Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization
    Matthew Kerrigan
    Department of Pharmacy, University of Washington, Seattle, and the Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, Washington 98109, USA
    Med Care 43:1043-8. 2005
  8. ncbi request reprint Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program
    Matthew J Hayat
    Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd, Suite 504, Bethesda, Maryland 20892 8315, USA
    Oncologist 12:20-37. 2007
  9. ncbi request reprint Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 109:2222-8. 2007
  10. pmc Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer
    Nadia Howlader
    Data Analysis and Interpretation Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Am J Epidemiol 176:347-56. 2012

Detail Information

Publications18

  1. doi request reprint Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States
    Nadia Howlader
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland Department of Epidemiology and Biostatistics, The George Washington University Milken Institute School of Public Health, Washington, D C
    Cancer Epidemiol Biomarkers Prev 25:1289-96. 2016
    ..The human immunodeficiency virus (HIV) epidemic has strongly influenced non-Hodgkin lymphoma (NHL) incidence in the U.S. general population, but its effects on NHL mortality trends are unknown...
  2. pmc US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status
    Nadia Howlader
    Affiliations of authors Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda MD NH, SFA, LAGR, KAC Department of Epidemiology, University of Washington, Seattle, WA CIL Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA CIL Louisiana Tumor Registry and Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA VWC Cancer Prevention Institute of California, Fremont, CA CAC National Cancer Institute Contractor, RiesSearch, LLC, Rockville MD LAGR
    J Natl Cancer Inst 106:. 2014
    ..In 2010, Surveillance, Epidemiology, and End Results (SEER) registries began collecting human epidermal growth factor 2 (HER2) receptor status for breast cancer cases...
  3. pmc Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends
    Nadia Howlader
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland Department of Epidemiology and Biostatistics, The George Washington University Milken Institute School of Public Health, Washington DC
    Cancer Epidemiol Biomarkers Prev 25:174-9. 2016
    ..Although mortality from NHL overall has changed dramatically in the United States over time, little is known about trends for subtypes, because death certificates do not record this information...
  4. pmc Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death
    Nadia Howlader
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD NH, AM Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT SW, LMS
    J Natl Cancer Inst Monogr 2014:255-64. 2014
    ..But clinicians and cancer patients generally want to understand actual prognosis (crude measures): the chance of surviving, dying from the specific cancer and from competing causes of death in a given time period...
  5. pmc The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries
    Nadia Howlader
    Cancer Statistic Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd Suite 504, Bethesda, MD 20892 8315, USA
    J Natl Cancer Inst 101:533-6. 2009
    ..015, 1.012, and 1.035 for all races, white males, and black males, respectively. Modest changes in long-term incidence trends were observed, particularly in black males...
  6. pmc Improved estimates of cancer-specific survival rates from population-based data
    Nadia Howlader
    Data Analysis and Interpretation Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd, Ste 504, Bethesda, MD 20892 8315, USA
    J Natl Cancer Inst 102:1584-98. 2010
    ..Because life tables for all subgroups in a study may be unavailable, we investigated whether cause-specific survival could be used as an alternative for relative survival...
  7. ncbi request reprint Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization
    Matthew Kerrigan
    Department of Pharmacy, University of Washington, Seattle, and the Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, Washington 98109, USA
    Med Care 43:1043-8. 2005
    ..Colorectal cancer is relatively frequent among adults of working age, yet few studies have examined treatment, outcomes, and costs for people under 65 years of age with this disease...
  8. ncbi request reprint Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program
    Matthew J Hayat
    Division of Cancer Control and Population Sciences, National Cancer Institute, 6116 Executive Blvd, Suite 504, Bethesda, Maryland 20892 8315, USA
    Oncologist 12:20-37. 2007
    ..The impact on the future U.S. cancer burden is estimated based on the growing and aging U.S. population. The number of new cancer patients is expected to more than double from 1.36 million in 2000 to almost 3.0 million in 2050...
  9. ncbi request reprint Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer 109:2222-8. 2007
    ..The population included Medicare patients (age >or=65 years) who were diagnosed with local or regional stage colorectal cancer between 1986 and 1996...
  10. pmc Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer
    Nadia Howlader
    Data Analysis and Interpretation Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Am J Epidemiol 176:347-56. 2012
    ..This is the first time that a nationally representative, population-based cancer registry data set has been imputed and made available to researchers for conducting a variety of analyses of breast cancer incidence trends...
  11. doi request reprint Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010
    Nadia Howlader
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland
    Cancer 120:3771-80. 2014
    ..The objectives of this report are to: 1) assess the completeness of the new SSFs and discuss their limitations and 2) discuss key changes in American Joint Committee on Cancer (AJCC) staging between the 6th and 7th editions...
  12. pmc Cancer survival: an overview of measures, uses, and interpretation
    Angela B Mariotto
    Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD AM, AN, NH, HC Division of Cancer Registration and Surveillance, National Cancer Center, Goyang si Gyeonggi do, Korea HC Information Management Services, Inc, Calverton MD GEK, JG Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Geisel School of Medicine at Dartmouth, Hanover, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT SW, LMS
    J Natl Cancer Inst Monogr 2014:145-86. 2014
    ..In addition, we introduce templates to summarize cancer survival statistic organized by their specific purpose: research and policy versus prognosis and clinical decision making. ..
  13. pmc Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes
    Arnold L Potosky
    Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven St NW, Ste 4100, Washington, DC 20007, USA
    J Natl Cancer Inst 103:979-82. 2011
    ..This finding suggests that policies to decrease CSF use in patients at lower or intermediate risk of FN may yield substantial cost savings without compromising patient outcomes...
  14. pmc Cancer incidence and survival trends by subtype using data from the Surveillance Epidemiology and End Results Program, 1992-2013
    Anne Michelle Noone
    Surveillance Research Program, National Cancer Institute
    Cancer Epidemiol Biomarkers Prev . 2016
    ....
  15. ncbi request reprint Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M2 B230, Seattle, WA 98109, USA
    J Clin Oncol 22:4971-8. 2004
    ..Using the Surveillance, Epidemiology and End Results (SEER)-Medicare database, we examined community treatment patterns for advanced NSCLC, focusing on chemotherapy...
  16. pmc Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
    Betsy A Kohler
    North American Association of Central Cancer Registries, Springfield, IL BAK, RLS, KAH, FPB National Cancer Institute, Bethesda, MD NH, KAC, AMN, LP American Cancer Society, Atlanta, GA AJ Centers for Disease Control and Prevention, Atlanta, GA ABR, SJH, CRE Temple University Department of Geography, Philadelphia, PA KAH New York State Cancer Registry, NY FPB Information Management Services, Inc, Rockville, MD AL National Center for Health Statistics, Hyattsville, MD RNA
    J Natl Cancer Inst 107:djv048. 2015
    ..This Annual Report includes a focus on breast cancer incidence by subtype using new, national-level data...
  17. ncbi request reprint Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial
    Ruth D Etzioni
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    J Urol 174:877-81. 2005
    ..We estimated the long-term effects of finasteride on PSA in men with and without a prostate cancer diagnosis at the end of the study...
  18. ncbi request reprint Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease
    Vincent S Fan
    Health Services Research and Development Center of Excellence, Veterans Affairs Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108 1597, USA
    Arch Intern Med 167:2345-53. 2007
    ....